Sesen Bio Inc expected to post a loss of 8 cents a share - Earnings Preview

Carisma Therapeutics

04/11/2022 18:33

* Sesen Bio Inc  SESN.OQ   SESN.O  is expected to show no
change
in quarterly revenue when it reports  results on November 7
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Sesen Bio Inc is
for a
loss of 8 cents per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sesen Bio
Inc is
$0.8​, above​ its last closing price of $0.56. ​​​

This summary was machine generated November 4 at 18:32 GMT.  All
figures in US dollars  unless otherwise stated